• Home
  • |
  • Press Release
  • |
  • Global Hospital Acquired Disease Testing Market Modernization of Healthcare Infrastructure Impelling Growth

Global Hospital Acquired Disease Testing Market to Reach US$ 27.7 Billion by 2028, Modernization of Healthcare Infrastructure Impelling Growth

May 16, 2019

According to the latest report by IMARC Group, titled “Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global hospital acquired disease testing market reached a value of US$ 10.3 Billion in 2022. A hospital-acquired infection (HAI), also known as a nosocomial infection, is acquired from hospitals or clinical surroundings such as nursing homes and rehabilitation centers. In several cases, HAI can also be traced in the patient’s microbiome when the protective layer of skin comes in contact with possible threats, which cause infection, particularly after surgical operations. The incubation period of these diseases generally varies from 48 hours to 4 days. Some of the commonly occurring infections include pneumonia, urinary tract infections (UTI) and primary bloodstream infections.

Global Hospital Acquired Disease Testing Market Trends:

Most patients develop HAIs when they are admitted in emergency rooms (ERs) or intensive care units (ICUs) due to the presence of infected patients as well as contaminated linens, air droplets and hospital equipment. In recent years, owing to rapid urbanization, increasing global population, and modernization of healthcare infrastructure, the number of healthcare facilities has grown around the world, which has consequently led to a rise in the instances of HAIs. Moreover, with continuous innovation in the healthcare sector, various technologies have been developed to prevent, diagnose and monitor HAIs like microarrays, solid phase hybridization, polymerase chain reaction (PCR) and real-time location systems (RTLSs). Some of the other growth-inducing factors are inflating morbidity rates, increasing geriatric population, lack of proper hygiene in hospitals and rise in multi-drug resistant organisms (MDROs). Looking forward, the market is projected to reach a value of US$ 27.7 Billion by 2028, expanding at a CAGR of 17.57% during 2023-2028.

Market Summary:

  • Based on the indication, the market has been classified into UTI, surgical site infection (SSI), pneumonia, bloodstream infections, methicillin-resistant staphylococcus aureus (MRSA), and others. Currently, UTI dominates the market, holding the largest share.
  • Region-wise, the market has been segregated into Europe, Asia Pacific, North America, Latin America, and Middle East and Africa. At present, North America is the biggest market, holding the majority of the global share.
  • The competitive landscape of the market has also been examined in the report with the detailed profiles of the leading market players. Some of the key players are Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, F. Hoffmann-La Roche Ltd., Hologic, Inc., QIAGEN, Siemens Healthcare, Diatherix Laboratories, Inc., Meridian Bioscience, Inc., Thermo Fisher Scientific, Inc. (Life Technologies Corporation) and Cepheid, Inc.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Global Hospital Acquired Disease Testing Market to Reach US$ 27.7 Billion by 2028, Modernization of Healthcare Infrastructure Impelling Growth
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More